Standard Life Aberdeen Stock London S.E.
Equities
GB00BVFD7Q58
Investment Management & Fund Operators
Sales 2024 * | 1.32B 1.68B | Sales 2025 * | 1.31B 1.67B | Capitalization | 2.83B 3.6B |
---|---|---|---|---|---|
Net income 2024 * | 98M 125M | Net income 2025 * | 134M 171M | EV / Sales 2024 * | 1.63 x |
Net cash position 2024 * | 688M 876M | Net cash position 2025 * | 645M 822M | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
27.7
x | P/E ratio 2025 * |
21
x | Employees | - |
Yield 2024 * |
9.21% | Yield 2025 * |
9.21% | Free-Float | 97.59% |
Latest transcript on Standard Life Aberdeen
Managers | Title | Age | Since |
---|---|---|---|
Jason Windsor
CEO | Chief Executive Officer | 51 | 23-10-30 |
David Scott
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-31 |
Mark Dixon
CTO | Chief Tech/Sci/R&D Officer | 62 | 10-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Flint
CHM | Chairman | 67 | 18-10-31 |
Director/Board Member | 68 | 18-07-31 | |
John Devine
BRD | Director/Board Member | 66 | 16-07-03 |
1st Jan change | Capi. | |
---|---|---|
-3.68% | 117B | |
+7.89% | 97.97B | |
+15.16% | 68.65B | |
+21.20% | 64.23B | |
+13.53% | 43.62B | |
+16.10% | 43.12B | |
+21.85% | 35.88B | |
+9.76% | 26.11B | |
-2.67% | 22.54B |